Inspire Medical Investors Face Jan. 5 Lead‑Plaintiff Deadline in Securities Suits Over Inspire V

Overview

• The Schall Law Firm, DJS Law Group, and Rosen Law Firm issued fresh notices inviting INSP shareholders from August 6, 2024 to August 4, 2025 to contact them about the case.
• Complaints say Inspire told investors it was fully prepared for the Inspire V rollout and touted high demand, but the launch drew weak uptake and lacked basic steps to speed clinician adoption.
• The actions assert violations of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5.
• Rosen’s notice states a class action has been filed, though no class has been certified and investors are not represented unless they retain counsel.
• Motions to serve as lead plaintiff are due January 5, 2026, and appointment is not required to participate in any potential recovery.